KAKKIS EMIL D

CIK 00012480932 companiesNOVATO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001248093

Recent Transactions

50 trades

Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-12-29$47.87/sh−30,000→ 569,770 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-12-29$47.87/sh−30,000→ 569,770 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-12-29$47.87/sh−30,000→ 569,770 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2023-12-29$47.87/sh−30,000→ 569,770 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-12-30$45.57/sh−19,582→ 541,108 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-12-30$45.57/sh−19,582→ 541,108 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-12-30$45.57/sh−19,582→ 541,108 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2022-12-30$45.57/sh−19,582→ 541,108 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$114.61/sh−605→ 575,640 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$112.91/sh−2,191→ 578,947 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$113.83/sh−2,702→ 576,245 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$114.61/sh−605→ 575,640 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$112.91/sh−2,191→ 578,947 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-31$113.83/sh−2,702→ 576,245 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$115.56/sh−3,600→ 583,738 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$116.31/sh−2,600→ 581,138 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$116.31/sh−2,600→ 581,138 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$113.30/sh−2,837→ 592,803 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$115.56/sh−3,600→ 583,738 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$114.61/sh−5,465→ 587,338 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$114.61/sh−5,465→ 587,338 total
Sale
Ultragenyx Pharmaceutical Inc.$RARE
Common Stock
2015-12-30$113.30/sh−2,837→ 592,803 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$6.43/sh+10,417→ 50,038 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2009-01-02−10,417→ 567,583 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$6.13/sh+6,583→ 56,621 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$17.57/sh−17,000→ 39,621 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$17.57/sh−17,000→ 39,621 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$6.43/sh+10,417→ 50,038 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2009-01-02−6,583→ 561,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2009-01-02$6.13/sh+6,583→ 56,621 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2009-01-02−6,583→ 561,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2009-01-02−10,417→ 567,583 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Restricted Stock Unit
2008-07-07−2,500→ 16,500 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-07-07+2,500→ 163,304 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-07-07+2,500→ 163,304 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Restricted Stock Unit
2008-07-07−2,500→ 16,500 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2008-04-29−75,000→ 599,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy)
2008-04-29−75,000→ 599,000 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-04-29$4.00/sh+75,000→ 161,164 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-04-29$4.00/sh+75,000→ 161,164 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.07/sh−400→ 98,164 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.06/sh−500→ 98,564 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.04/sh−1,200→ 99,564 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.22/sh−200→ 94,664 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.16/sh−200→ 95,364 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.01/sh−1,300→ 102,464 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.15/sh−300→ 95,564 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$4.00/sh+18,000→ 104,164 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.06/sh−500→ 98,564 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2008-03-06$38.20/sh−200→ 95,164 total

Companies

Recent Filings

Address

C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT

NOVATO, CA, 94949

View on SEC.gov